Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
142 studies found for:    "Dengue fever"
Show Display Options
Rank Status Study
1 Recruiting Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
Condition: Dengue Fever
Intervention: Other: case/control
2 Completed Role of Andi-d in Dengue Fever: a Pilot Study
Condition: Dengue Fever
Intervention: Drug: anti-d
3 Not yet recruiting Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore
Condition: Dengue Fever
Interventions: Drug: Celgosivir;   Drug: Modipafant 50mg;   Drug: Placebo;   Drug: Modipafant 100mg
4 Completed Diagnosis and Characterization of Dengue Fever in Children
Condition: Dengue Fever
Intervention:
5 Completed Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease
Condition: Dengue Fever
Interventions: Biological: DENV-1 PIV, 2.5 µg;   Biological: DENV-1 PIV, 5 µg
6 Recruiting Studies on the Pathogen, Vector Control and Clinical Treatment of Dengue Fever in Guangzhou
Condition: Dengue Fever
Intervention:
7 Completed Adult Dengue Platelet Study
Condition: Dengue Fever
Interventions: Procedure: Platelet transfusion;   Other: Supportive care
8 Completed
Has Results
A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children
Condition: Dengue Fever
Interventions: Biological: Dengue Vaccine Formulation 17;   Biological: Licensed Japanese Encephalitis (JE) Vaccine
9 Active, not recruiting A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)
Condition: Dengue Fever
Interventions: Biological: Biological/Vaccine: 4 µg TDENV-PIV with Alum adjuvant;   Biological: Biological/Vaccine: 1 µg TDENV-PIV with AS03B adjuvant;   Other: Phosphate buffered saline;   Biological: 1 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS01E adjuvant
10 Active, not recruiting A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: 4 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS03B1 adjuvant;   Other: Phosphate buffered saline;   Biological: 1 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS01E1 adjuvant
11 Completed Laboratory Diagnosis and Prognosis of Severe Dengue
Condition: Dengue Fever
Intervention:
12 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: rDEN1delta30;   Biological: Placebo
13 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: rDEN2/4delta30(ME) Vaccine;   Biological: Placebo
14 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: rDEN4delta30-200,201;   Biological: Placebo
15 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31‐7164) in Healthy Adults
Condition: Dengue Fever
Intervention: Biological: rDEN3delta30/31‐7164
16 Completed International Research Consortium on Dengue Risk Assessment, Management, and Surveillance
Condition: Dengue Fever
Intervention: Other: Observation
17 Completed Celgosivir as a Treatment Against Dengue
Condition: Dengue Fever
Interventions: Drug: celgosivir;   Drug: placebo
18 Active, not recruiting Factors Associated With Poor Dengue Outcomes in Malaysia
Condition: Dengue Fever
Intervention:
19 Completed The Clinical Epidemiology of Hospitalized Dengue Cases in Malaysia
Condition: Dengue Fever
Intervention:
20 Completed Clinical Specimens Testing Program of Dengue Antigen Detection Reagents
Condition: Dengue Fever
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.